Evercore ISI Upgrades Laboratory Corporation of America (LH) to Buy

Evercore ISI upgraded Laboratory Corporation of America (NYSE: LH) from Hold to Buy with a price target of $132.00.

Analyst Michael Cherny notes the upgrades follows a deep dive into the standalone opportunity as well as the potential upside from the Covance acquisition.

Key business drivers highlighted by the analyst include:

• Improving underlying volume
• Impact from business re-engineering
• Central lab consolidation
• Improving clinical trial enrollment process
• More robust strategic offering across the entire diagnostic testing supply chain

For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.

Shares of Laboratory Corporation of America closed at $117.04 yesterday.

You May Also Be Interested In

• Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
• 'Catalysts on the horizon:' Airbnb (ABNB) upgraded to Buy at Mizuho, shares climb
• TechnipFMC (FTI) PT Raised to $30 at BTIG